Literature DB >> 15546091

Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database.

Vivian H Chu1, Christopher H Cabell, Elias Abrutyn, G Ralph Corey, Bruno Hoen, Jose M Miro, Lars Olaison, Martin E Stryjewski, Paul Pappas, Kevin J Anstrom, Susannah Eykyn, Gilbert Habib, Natividad Benito, Vance G Fowler.   

Abstract

Using a large cohort of patients from the International Collaboration on Endocarditis Merged Database, we compared coagulase-negative staphylococcal (CoNS) native-valve endocarditis (NVE) to NVE caused by more common pathogens. Rates of heart failure and mortality were similar between patients with CoNS NVE and patients with Staphylococcus aureus NVE, but rates for both groups were significantly higher than rates for patients with NVE due to viridans streptococci. These results emphasize the importance of CoNS as a cause of NVE and the potential for serious complications with this infection.

Entities:  

Mesh:

Year:  2004        PMID: 15546091     DOI: 10.1086/424878

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

1.  Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.

Authors:  Ingrid Bourgeois; Martine Pestel-Caron; Jean-Francois Lemeland; Jean-Louis Pons; Francois Caron
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  Conservative management of a brain abscess in a patient with Staphylococcus lugdunensis endocarditis.

Authors:  S Gianella; S Ulrich; B Huttner; R Speich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-07       Impact factor: 3.267

3.  Characteristics and analysis of risk factors for mortality in infective endocarditis.

Authors:  Hakan Leblebicioglu; Hava Yilmaz; Yesim Tasova; Emine Alp; Rabin Saba; Rahmet Caylan; Mehmet Bakir; Ayhan Akbulut; Bilgin Arda; Saban Esen
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

Review 4.  Epidemiology and antibiotic treatment of infective endocarditis: an update.

Authors:  Bruno Hoen
Journal:  Heart       Date:  2006-11       Impact factor: 5.994

Review 5.  The changing face of infective endocarditis.

Authors:  B D Prendergast
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

6.  Trends in endocarditis hospitalizations at US children's hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines.

Authors:  Sara K Pasquali; Xia He; Zeinab Mohamad; Brian W McCrindle; Jane W Newburger; Jennifer S Li; Samir S Shah
Journal:  Am Heart J       Date:  2012-05       Impact factor: 4.749

7.  Native valve endocarditis caused by coagulase negative staphylococci; an appeal to start outpatient antimicrobial therapy: an unusual case report.

Authors:  Nada Al-Tamtami; Jalila Al-Lawati; Seif Al-Abri
Journal:  Oman Med J       Date:  2011-07

8.  Clinical significance of coagulase-negative staphylococci other than S. epidermidis blood stream isolates at a tertiary care hospital.

Authors:  Florian Hitzenbichler; Michaela Simon; Bernd Salzberger; Frank Hanses
Journal:  Infection       Date:  2016-09-22       Impact factor: 3.553

9.  Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report.

Authors:  Marylene Duah
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-02-18       Impact factor: 3.944

10.  Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective.

Authors:  Cathy A Petti; Keith E Simmon; Jose M Miro; Bruno Hoen; Francesc Marco; Vivian H Chu; Eugene Athan; Suzana Bukovski; Emilio Bouza; Suzanne Bradley; Vance G Fowler; Efthymia Giannitsioti; David Gordon; Porl Reinbott; Tony Korman; Selwyn Lang; Cristina Garcia-de-la-Maria; Annibale Raglio; Arthur J Morris; Patrick Plesiat; Suzanne Ryan; Thanh Doco-Lecompte; Francesca Tripodi; Riccardo Utili; Dannah Wray; J Jeffrey Federspiel; K Boisson; L Barth Reller; David R Murdoch; Christopher W Woods
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.